OCT 03, 2018 7:15 AM PDT

Natural Killers for HIV Vaccine

WRITTEN BY: Nicholas Breehl

Human immunodeficiency virus or HIV is still a disease with no cure. With the incidence rate in the United States, reported by the Centers for Disease Control and Prevention (CDC), at 38,500 diagnoses in 2015, scientists across the globe continue to work diligently to combat HIV.

A team of researchers from Duke Human Vaccine Institute has recently published their work regarding the interplay of natural killer cells (NK cells) and broadly neutralizing antibodies (bnAbs) in the journal Cell. Their efforts hope to provide insight into the development of a vaccine that can be made to protect individuals from future infection.

About half of those infected with HIV experience production of broadly neutralizing antibodies, while the other 50% do not develop bnAbs. Broadly neutralizing antibodies are naturally occurring antibodies that develop too late in ones HIV infection to provide any benefit. This is because HIV has a high mutation rate and the antibodies would no longer recognize the virus.

If administered early enough, the bnAbs show potential in the development and efficacy of a vaccine. To begin, the researchers must understand the molecular mechanisms of host control of bnAb induction. To this end, the team performed a transcriptome analysis of the blood from about 50 HIV-1 bnAb producing patients and around 50 patients with HIV-1 that do not produce bnAbs. Transcriptome analysis is a catalog of the complete set of RNA transcripts that are generated by the genome.

The scientists observed an upregulation of RAB11FIP5 gene that encodes a Rab protein associated with endosomes. NK cells had the highest expression of the gene, which is presumed to be related to dysfunction of the NK cells. NK cells are involved in the regulation of immune cells, specifically CD4+ T follicular helper cells, the cells that interact with B cells to produce antibodies.

This data suggest that NK cells and Rab11 are part of the regulation of HIV-1 bnAb development.

Barton Haynes, M.D., director of the Duke Human Vaccine Institute and senior author of the study says, “This type of immune cell wasn’t previously known to regulate bnAbs. We found a new natural killer cell pathway that appears to be important in regulating the bnAb production.”

Todd Bradley, Ph. D., a lead author of the study, states, “This is a new pathway that we hope to modulate during vaccination to generate a better HIV antibody response.”

The research team identifies future work should focus to identify the specific receptor-ligand interactions involved in triggering of NK cell lysis of CD4+ T cells. They would also like to see if blocking these interactions improves antibody responses during vaccination.

Sources: Science Direct, Science Daily, CDC, Youreka Science

About the Author
You May Also Like
JUL 29, 2020
Immunology
Immune Variation Explains Different COVID-19 Outcomes
JUL 29, 2020
Immune Variation Explains Different COVID-19 Outcomes
Immune systems respond differently to coronavirus infection. People experience the disease causes by coronavirus, COVID- ...
AUG 25, 2020
Immunology
Targeting Checkpoint Molecule Could Mean Checkmate for Cancer
AUG 25, 2020
Targeting Checkpoint Molecule Could Mean Checkmate for Cancer
In a new study published in Cell, researchers have identified a metabolic enzyme that could have powerful tumor-killing ...
SEP 02, 2020
Immunology
Alarmins: The Immune "Gold" in Breast Milk
SEP 02, 2020
Alarmins: The Immune "Gold" in Breast Milk
We know that infants fed with breast milk develop more robust immune systems as a result of factors that support the nat ...
SEP 20, 2020
Drug Discovery & Development
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
SEP 20, 2020
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
Biopharmaceutical company Bristol-Myers Squibb has found that a new drug combination can reduce death rates among those ...
OCT 08, 2020
Immunology
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
OCT 08, 2020
Air Pollution Particles Detected in the Placenta, Immune Cells Mop Them Up
Tiny, black particles much like those found in polluted air have been found in the placentas of pregnant women, as repor ...
NOV 06, 2020
Immunology
The Coronavirus Is No Match Against Sybody 23
NOV 06, 2020
The Coronavirus Is No Match Against Sybody 23
The virus that causes COVID-19, SARS-CoV-2, uses its spike protein to gain access to cells, by binding to the ACE2 recep ...
Loading Comments...